Shareholder derivative litigation

Search documents
Kuehn Law Encourages Investors of United Natural Foods, Inc. to Contact Law Firm
Prnewswire· 2025-07-30 20:33
Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of United Natural Foods, Inc. (UNFI) [1] Group 1: Allegations of Misrepresentation - Insiders at United Natural Foods allegedly caused the company to misrepresent or fail to disclose critical information regarding its operations and financial health [2] - The company did not invest in improving its data management and related infrastructure despite its cost-saving Value Path initiative [2] - As a result of inadequate infrastructure, United Natural Foods could not respond effectively to cost changes, including inflationary pressures [2] - The company failed to recognize the benefits of procurement and inventory gains achieved during fiscal 2022, adversely impacting profitability [2] - Positive statements made about the company's business, operations, and prospects were deemed materially misleading or lacking a reasonable basis [2]
Kuehn Law Encourages Investors of Napco Security Technologies, Inc. to Contact Law Firm
GlobeNewswire News Room· 2025-07-02 14:24
Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by officers and directors of Napco Security Technologies, Inc. related to misrepresentation of the company's growth and hardware division performance [1][2]. Group 1: Legal Investigation - Kuehn Law is looking into whether certain insiders at Napco Security misrepresented the company's expected growth and strength in its hardware division [2]. - The investigation is prompted by a federal securities lawsuit alleging that insiders caused the company to misrepresent its ability to meet fiscal 2026 growth projections [2]. Group 2: Shareholder Information - Shareholders who purchased NSSC shares prior to February 5, 2024, are encouraged to contact Kuehn Law for potential legal action [3]. - Kuehn Law covers all case costs and does not charge its investor clients, emphasizing the importance of shareholder participation in maintaining market integrity [4].
Kuehn Law Encourages Investors of BigBear.ai Holdings, Inc. to Contact Law Firm
Prnewswire· 2025-06-11 14:11
Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by officers and directors of BigBear.ai Holdings, Inc. (NYSE: BBAI) towards shareholders [1] Group 1: Legal Investigation - A federal securities lawsuit alleges that insiders at BigBear.ai misrepresented or failed to disclose critical accounting issues, including deficient accounting review policies [2] - The lawsuit claims that BigBear incorrectly accounted for the 2026 Convertible Notes, failing to bifurcate the conversion option as required by accounting standards [2] - Due to these errors, BigBear's financial statements were inaccurate and may need to be restated, increasing the risk of delays in filing financial reports with the U.S. Securities and Exchange Commission [2] Group 2: Shareholder Action - Shareholders who purchased BBAI shares prior to March 31, 2022, are encouraged to contact Kuehn Law for potential legal action, as there may be limited time to enforce their rights [3] - Kuehn Law offers to cover all case costs and does not charge investor clients, emphasizing the importance of shareholder participation in maintaining market integrity [4]
Kuehn Law Encourages Investors of Axsome Therapeutics, Inc. to Contact Law Firm
Prnewswire· 2025-04-08 18:03
Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Axsome Therapeutics, Inc. related to misrepresentation of the company's practices and prospects [1] Group 1: Allegations of Misrepresentation - Insiders at Axsome allegedly caused the company to misrepresent or fail to disclose deficiencies in its chemistry, manufacturing, and control (CMC) practices concerning AXS-07 [2] - As a result of these deficiencies, Axsome was unlikely to submit the AXS-07 New Drug Application (NDA) on the initially represented timeline [2] - The unresolved CMC issues were present during the FDA's review of the AXS-07 NDA, leading to a low likelihood of FDA approval [2] - Consequently, Axsome overstated AXS-07's regulatory and commercial prospects, making the company's public statements materially false and misleading [2]
Kuehn Law Encourages Investors of New Fortress Energy Inc. to Contact Law Firm
Prnewswire· 2025-04-01 18:37
As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™ For additional information, please visit Shareholder Derivative Litigation - Kuehn Law. Attorney advertising. Prior results do not guarantee similar outcomes. Contacts: Kuehn Law, PLLC Justin Kuehn, Esq. 53 Hill Street, Suite 605 Southampton, NY 11968 [email protected] (833) 672-0814 SOURCE Kuehn Law, PLLC NEW YORK, April 1, 2025 /PRN ...